Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9312240 | Urology | 2005 | 5 Pages |
Abstract
These results suggest that terazosin reduces tumor vascularity and induces apoptosis in TCC of the bladder. Additional studies with more patients are necessary to reach definitive conclusions. However, considering the proven apoptotic action of terazosin in prostatic tissue, this study may have implications for the use of terazosin in the treatment of bladder TCC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Anastasios Tahmatzopoulos, Chad A. Lagrange, Li Zeng, Bonnie L. Mitchell, William T. Conner, Natasha Kyprianou,